SEC is an antiangiogenic virulence factor that promotes Staphylococcus aureus endocarditis independent of superantigen activity.
Kyle J KinneySharon S TangXiao-Jun WuPhuong M TranNikhila S BharadwajKatherine N Gibson-CorleyAna N ForsytheKatarina KulhankovaJenny E GumperzWilmara Salgado-PabónPublished in: Science advances (2022)
The superantigen staphylococcal enterotoxin C (SEC) is critical for Staphylococcus aureus infective endocarditis (SAIE) in rabbits. Superantigenicity, its hallmark function, was proposed to be a major underlying mechanism driving SAIE but was not directly tested. With the use of S. aureus MW2 expressing SEC toxoids, we show that superantigenicity does not sufficiently account for vegetation growth, myocardial inflammation, and acute kidney injury in the rabbit model of native valve SAIE. These results highlight the critical contribution of an alternative function of superantigens to SAIE. In support of this, we provide evidence that SEC exerts antiangiogenic effects by inhibiting branching microvessel formation in an ex vivo rabbit aortic ring model and by inhibiting endothelial cell expression of one of the most potent mediators of angiogenesis, VEGF-A. SEC's ability to interfere with tissue revascularization and remodeling after injury serves as a mechanism to promote SAIE and its life-threatening systemic pathologies.
Keyphrases
- staphylococcus aureus
- endothelial cells
- biofilm formation
- aortic valve
- vascular endothelial growth factor
- methicillin resistant staphylococcus aureus
- left ventricular
- signaling pathway
- oxidative stress
- escherichia coli
- pseudomonas aeruginosa
- mitral valve
- climate change
- percutaneous coronary intervention
- coronary artery bypass grafting
- pulmonary artery
- acute coronary syndrome
- pulmonary hypertension
- drug induced
- pulmonary arterial hypertension